Real-world evidence: randomised trials in daily practice - 2nd KCE Trials symposium
- Attendance is free, but prior registration is required.
Each presentation will be followed by a Q&A session. There will be no simultaneous translation.
RIZIV-INAMI accreditation in ethics and health economics has been requested.
KCE Trials selects and funds randomised trials on medical interventions in real life,
But how to design such trials? What are the challenges to conduct them and why are they important for healthcare policy decisions? What are registry-based randomised trials?
|9.20||Welcome||Raf Mertens, General Director, KCE (BE)|
|9.30||Welcome|| Maggie De Block, Minister of Social Affairs
and Public Health (BE)
|9.40||Introduction to pragmatic trials including cluster randomised trials and stepped wedge design|| Sandra Eldridge, Barts and The London School
of Medicine and Dentistry (UK)
|10.10||Update on KCE Trials and the BeNeLux call||Frank Hulstaert, KCE (BE)|
|10.35||Hands on experience with registry-based randomised trials and how you can make it work|| Jonas Oldgren, Uppsala Clinical Research Center
|11.45||Centralised ICT support for registries and trials in Belgium||Johan Van Bussel, Healthdata.be (BE)|
|12.05||Low intervention trials and registry-based randomised trials, the regulatory perspective|| Greet Musch, Federal Agency for Medicines
and Health Products (BE)
|13.30||Pragmatic trials, ethics and informed consent considerations||Shona Kalkman, University Medical Center Utrecht (NL)|
|14.00||Which outcomes are important to patients: the Core Outcome Measures in Effectiveness Trials
|Paula Williamson, University of Liverpool (UK)|
|14.30||How to define a clinically relevant difference: the DELTA (Difference ELicitation in TriAls) project||Jonathan Cook, University of Oxford (UK)|
|15.00||A clinical trials management system (CTMS) for hospitals||France Vrijens, KCE (BE)|
|15.05||Closure||Frank Hulstaert, KCE (BE)|